Skandinaviska Enskilda Banken (SEB)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,970
Closed -$16.2M 424
2025
Q4
$16.2M Buy
23,970
+2,021
+9% +$1.38M 0.07% 209
2025
Q3
$14M Sell
21,949
-1,386
-6% -$841K 0.06% 228
2025
Q2
$12.5M Buy
23,335
+6,978
+43% +$3.34M 0.05% 253
2025
Q1
$6.87M Sell
16,357
-2,556
-14% -$1.11M 0.03% 348
2024
Q4
$7.81M Buy
18,913
+1,900
+11% +$833K 0.04% 337
2024
Q3
$8.6M Hold
17,013
0.04% 293
2024
Q2
$8.29M Buy
17,013
+1
+0% +$502 0.04% 292
2024
Q1
$9.19M Sell
17,012
-133
-0.8% -$72.7K 0.04% 289
2023
Q4
$9.52M Buy
17,145
+520
+3% +$244K 0.06% 268
2023
Q3
$7.27M Buy
16,625
+203
+1% +$101K 0.05% 304
2023
Q2
$8.25M Buy
16,422
+1,749
+12% +$838K 0.05% 293
2023
Q1
$7.34M Sell
14,673
-371
-2% -$178K 0.05% 313
2022
Q4
$6.14M Sell
15,044
-114
-0.8% -$44.3K 0.05% 324
2022
Q3
$4.94M Sell
15,158
-14,441
-49% -$5.3M 0.04% 365
2022
Q2
$10.4M Sell
29,599
-992
-3% -$405K 0.08% 238
2022
Q1
$16.7M Sell
30,591
-51,244
-63% -$27M 0.1% 197
2021
Q4
$54.1M Sell
81,835
-31,237
-28% -$19.6M 0.28% 74
2021
Q3
$70.3M Sell
113,072
-3,499
-3% -$2.35M 0.39% 59
2021
Q2
$73.6M Buy
116,571
+9,857
+9% +$5.44M 0.45% 43
2021
Q1
$52.2M Sell
106,714
-48,000
-31% -$24M 0.34% 63
2020
Q4
$77.3M Buy
154,714
+13,621
+10% +$6.09M 0.53% 35
2020
Q3
$55.5M Buy
141,093
+61,661
+78% +$22.8M 0.41% 57
2020
Q2
$26.2M Buy
79,432
+8,654
+12% +$2.51M 0.21% 92
2020
Q1
$17.1M Buy
70,778
+52,661
+291% +$13.7M 0.17% 120
2019
Q4
$4.73M Sell
18,117
-152,831
-89% -$40.3M 0.04% 353
2019
Q3
$46.5M Buy
170,948
+64,175
+60% +$17.9M 0.39% 60
2019
Q2
$29.4M Buy
106,773
+92,348
+640% +$22.8M 0.25% 89
2019
Q1
$3.23M Sell
14,425
-607
-4% -$125K 0.03% 363
2018
Q4
$2.8M Buy
15,032
+1,851
+14% +$379K 0.03% 377
2018
Q3
$3.29M Sell
13,181
-1,330
-9% -$323K 0.03% 376
2018
Q2
$3.16M Sell
14,511
-52,723
-78% -$10.9M 0.03% 343
2018
Q1
$12.9M Sell
67,234
-1,995
-3% -$368K 0.12% 127
2017
Q4
$10.8M Sell
69,229
-36,018
-34% -$5.67M 0.09% 175
2017
Q3
$16.4M Sell
105,247
-36,100
-26% -$5.71M 0.15% 124
2017
Q2
$22.8M Sell
141,347
-600
-0.4% -$97.4K 0.22% 107
2017
Q1
$21.9M Hold
141,947
0.22% 94
2016
Q4
$16.6M Buy
141,947
+123,247
+659% +$14.1M 0.2% 89
2016
Q3
$2.11M Buy
18,700
+14,800
+379% +$1.56M 0.02% 460
2016
Q2
$362K Buy
+3,900
New +$335K ﹤0.01% 650

Other funds holding IDXX

Skandinaviska Enskilda Banken (SEB)'s IDXX Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 23,970 shares — an estimated $16.2M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IDXX in Q2 2016 and held it in 39 quarters. The position peaked at $77.3M in Q4 2020. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 23,970 Idexx Laboratories shares in Q1 2026, an estimated $16.2M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Idexx Laboratories in Q2 2016 and held it in 39 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Idexx Laboratories position peaked at $77.3M in Q4 2020.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.